Severe Hypertriglyceridemia: Clinical Trials

8 trials for Severe Hypertriglyceridemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 8
Phase 21Completed 1

Follow Severe Hypertriglyceridemia: new trials by email Literature Review of Severe Hypertriglyceridemia trials Research Report on Severe Hypertriglyceridemia

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Plozasiran in Adults With Severe Hypertriglyceridemia
Plozasiran Injection, Placebo - Severe Hypertriglyceridemia
Phase 3CompletedArrowhead Pharmaceuticals3112024-07-232026-10-09
Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia
Plozasiran Injection, Placebo - Severe Hypertriglyceridemia
Phase 3CompletedArrowhead Pharmaceuticals4462024-07-222026-10-08
To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia
Pegozafermin, Placebo - Severe Hypertriglyceridemia
Phase 3Completed89bio, Inc.3692023-06-152026-07-07
A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia
Olezarsen, Placebo - Severe Hypertriglyceridemia
Phase 3CompletedIonis Pharmaceuticals, Inc.4462022-08-312025-10-22
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
Olezarsen, Placebo - Severe Hypertriglyceridemia
Phase 3CompletedIonis Pharmaceuticals, Inc.6172021-10-252026-02-10
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function
K-877, Fenofibrate, Placebo (for K-877) - Severe Hypertriglyceridemia
Phase 3CompletedKowa Research Institute, Inc.5512016-11-282022-11-30
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment
K-877, Fenofibrate, Placebo (for K-877) - Severe Hypertriglyceridemia
Phase 3CompletedKowa Research Institute, Inc.4712016-11-262022-10-28
Epanova® for Lowering Very High Triglycerides
placebo, omefas - Severe Hypertriglyceridemia
Phase 2 / Phase 3CompletedAstraZeneca3992011-01-012016-08-04

Narrower conditions

Hypertriglyceridemia (8)  ·  Hyperlipidemias (3)  ·  Dyslipidemias (2)  ·  Metabolic Diseases (2)  ·  Lipid Metabolism Disorders (1)

Broader conditions

Nutritional and Metabolic Diseases (8)  ·  Lipid Metabolism Disorders (7)  ·  Dyslipidemias (6)  ·  Metabolic Diseases (6)  ·  Hyperlipidemias (5)

Interventions

Fenofibrate (2)  ·  K-877 compound (2)  ·  olezarsen (2)  ·  plozasiran (2)

Sponsors

Arrowhead Pharmaceuticals (2)  ·  Ionis Pharmaceuticals, Inc. (2)  ·  Kowa Research Institute, Inc. (2)  ·  89bio, Inc. (1)  ·  AstraZeneca (1)

Countries

Hungary (8)  ·  United States (8)  ·  Bulgaria (7)  ·  Czechia (7)  ·  Poland (7)  ·  Canada (5)  ·  Spain (5)  ·  Argentina (4)  ·  France (4)  ·  Italy (4)  ·  Slovakia (4)  ·  Belgium (3)  ·  Brazil (3)  ·  Georgia (3)  ·  Germany (3)

Top investigators

Michael H Davidson, MD, FACC (1)  ·  Teresa Parli, MD (1)

Results publications

PMID 40064331, PMID 41211918, PMID 24528690

NIH funding

2023 (3)